
Chase McWhorter, Institutional Real Estate, Inc.’s managing director, recently spoke with Olivia Drew, Portfolio Manager – UK Life Sciences, on the key themes in:
The life science real estate sector
A sector comprising of properties specifically designed and built for companies who require high-specification facilities that meet their unique needs.
High demand, low supply and the global differences
With life sciences, particularly in the United Kingdom and Europe, many of the facilities don’t yet exist today, and there is a strong level of demand but very little supply.
Social advantages and mitigating environmental impact
How the social impact can be measured and in what ways it is possible to mitigate some of the environmental impact of the higher energy costs relative to office space.
Best ways for investors to access the life science markets
What the challenges are in investing in underlying companies.
Related insights
- The WHO's WHO of Swiss real estate 2025
- On the rise?
- TRTPM monthly blog – Edition June 2025
- Resilience amid uncertainty
- Where resilient performance meets stability
- Global Real Estate Outlook – Edition May 2025
- Rewriting the rules
- Steering through market uncertainty
- Taking action!
- UK commercial real estate yields